News

Latest news

10th January 2023

Update on Acticor Biotech's clinical developments with glenzocimab in the treatment of cardiovascular emergencies

Read more
4th January 2023

M&A情報サイト「MARR Online（マールオンライン）」インタビュー記事掲載のお知らせ

Read more
23rd December 2022

Acticor Biotech provides an update on the US regulatory discussion with the FDA

Read more
15th November 2022

Sequana Medical announces positive top-line results from SAHARA Ph. 2a study of DSR 1.0 in diuretic-resistant heart failure patients with persistent congestion and first patient dosed successfully with DSR 2.0 in YUKON

Read more
7th November 2022

Dr Michihiko Wada joins Newton Biocapital as an Advisor, Clinical and Medical Sciences

Read more
7th November 2022

ニュートン バイオキャピタル、和田 道彦博士とフィリップ デバッカー博士の参画で、 チーム体制をさらに強化

Read more
25th October 2022

Sequana Medical announces positive top-line results from the North American pivotal alfapump® study (POSEIDON)

Read more
24th October 2022

Data from Roll-In Cohort of North American pivotal alfapump® study (POSEIDON) selected for poster presentation at AASLD The Liver Meeting®

Read more
20th October 2022

Acticor Biotech strenghtens its financial structure

Read more